Brief: Monte Rosa Therapeutics Q1 Loss Per Share USD 0.65
11/05/2023 12:39
May 11 (Reuters) - Monte Rosa Therapeutics Q1 EPS USD -0.65. * Q1 operating expenses USD 34.259 million * Q1 operating income USD -34.259 million * Q1 net income USD -32.038 million
Recent news on Monte Rosa Therapeutics
See all newsBrief: Monte Rosa Therapeutics Announces Positive Results For Mrt-8102 In Gforce-1 Phase 1 Study Showing Normalization Of Key Pathogenic Drivers Of Ascvd In Subjects With Elevated Cvd Risk
Brief: Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Monte Rosa Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Monte Rosa Therapeutics Q2 revenue drops, net loss widens on higher R&D
Brief: Monte Rosa Therapeutics Q2 Collaboration Revenue USD 8.968 Million